Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D Locati

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Oral Oncology|July 27, 2005
Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary glandLaura D Locati, Marco Guzzo, Paolo Bossi, et al.
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
Cancer Biology & Therapy|March 13, 2014
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapyLaura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
European Thyroid Journal|November 16, 2016
Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid CancerLars Bastholt, Michael C Kreissl, Dagmar Führer, et al.
Frontiers in Oncology|December 12, 2022
Salivary gland cancers in elderly patients: challenges and therapeutic strategiesElena Colombo, Charlotte Van Lierde, Alexandra Zlate, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignanciesStefano Cavalieri, Daria Maria Filippini, Arianna Ottini, et al.
Oncology|May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor AgentsStefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 5, 2018
Lenvatinib-induced renal failure: two first-time case reports and review of literatureStefano Cavalieri, Laura Cosmai, Augusto Genderini, et al.
Translational Oncology|September 17, 2008
TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland CarcinomaTiziana Negri, Elena Tamborini, Gian Paolo Dagrada, et al.
Endocrine|November 24, 2023
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in EuropeChristelle de la Fouchardière, Laura Fugazzola, Laura D Locati, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Oral Oncology|July 27, 2005
Lung metastasectomy in adenoid cystic carcinoma (ACC) of salivary glandLaura D Locati, Marco Guzzo, Paolo Bossi, et al.
Future Oncology (London, England)|June 27, 2019
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapyPaolo Bossi, Laura Botta, Paolo Bironzo, et al.
Cancer Biology & Therapy|March 13, 2014
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapyLaura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
European Thyroid Journal|November 16, 2016
Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid CancerLars Bastholt, Michael C Kreissl, Dagmar Führer, et al.
Frontiers in Oncology|December 12, 2022
Salivary gland cancers in elderly patients: challenges and therapeutic strategiesElena Colombo, Charlotte Van Lierde, Alexandra Zlate, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignanciesStefano Cavalieri, Daria Maria Filippini, Arianna Ottini, et al.
Oncology|May 22, 2019
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor AgentsStefano Cavalieri, Federica Perrone, Massimo Milione, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 5, 2018
Lenvatinib-induced renal failure: two first-time case reports and review of literatureStefano Cavalieri, Laura Cosmai, Augusto Genderini, et al.
Translational Oncology|September 17, 2008
TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland CarcinomaTiziana Negri, Elena Tamborini, Gian Paolo Dagrada, et al.
Endocrine|November 24, 2023
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in EuropeChristelle de la Fouchardière, Laura Fugazzola, Laura D Locati, et al.
Pageof 7